Five-year outcomes of adjuvant carboplatin/paclitaxel chemotherapy and intravaginal radiation for stage I-II papillary serous endometrial cancer Academic Article uri icon

Overview

MeSH Major

  • Antineoplastic Combined Chemotherapy Protocols
  • Brachytherapy
  • Chemoradiotherapy, Adjuvant
  • Cystadenocarcinoma, Papillary
  • Cystadenocarcinoma, Serous
  • Endometrial Neoplasms

abstract

  • Concurrent adjuvant carboplatin/paclitaxel chemotherapy and IVRT provide excellent outcomes for early stage UPSC. Whether this regimen is superior to pelvic radiation will require confirmation from the ongoing randomized trial.

publication date

  • November 2012

Research

keywords

  • Academic Article

Identity

Language

  • eng

Digital Object Identifier (DOI)

  • 10.1016/j.ygyno.2012.07.112

PubMed ID

  • 22850412

Additional Document Info

start page

  • 321

end page

  • 5

volume

  • 127

number

  • 2